Literature DB >> 9669195

Noncompliance with antidepressants: who's to blame?

K Demyttenaere1.   

Abstract

Compliance with medical advice has always been a problem and there has always been discussion on who is to blame for noncompliance: the illness, the physician, the patient or the drug? A consensus between the physician's beliefs, views and representations of the nature and the etiology of the depression and of the treatment options on the one hand and the patient with his individual life story on the other is probably the best guarantee of reasonable compliance. In particular, a physician-patient consensus about the emotional meaning of the illness is essential: patients should be given the opportunity to express their feelings about the illness and what it signifies, and physicians should respond with feedback using the patient's concepts and emotional expression. Within this context of dialogue, patients may signal their resistance to and potential noncompliance with the physician's views. An empathic model of understanding can be used in the initial stages of the consultation. Finding an equilibrium between the cognitive-informational aspects of depressive illness and treatment on one hand and affective-motivational aspects on the other is a key factor in antidepressive treatment. Physicians should indeed always try to overcome the gap between the affective (empathy, motivational aspects) and the instrumental dimensions (correct diagnosis, adequate treatment) of their behavior.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669195

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  9 in total

1.  Point-counterpoint: the importance of "open access" to psychotropics for our patients.

Authors:  Alan D Schmetzer; John J Wernert
Journal:  Psychiatr Q       Date:  2006

2.  To adhere or not, and what we can do to help.

Authors:  F McNicholas
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-09-04       Impact factor: 4.785

3.  Economic factors in of patients' nonadherence to antidepressant treatment.

Authors:  Haekyung Jeon-Slaughter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-03-14       Impact factor: 4.328

4.  The Effect of Brochures and Audiotape on Efficacy and Tolerability of Venlafaxine in Depressed Outpatients: A Single-Blind Parallel Study in General Practice.

Authors:  Jan B. Deijen; Hilde Kornaat; Petronella A. Cloin
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-06

5.  Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment.

Authors:  Kaustav Chakraborty; Ajit Avasthi; Suresh Kumar; Sandeep Grover
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

6.  Alendronate soluble solution: a higher adherence rate in the treatment of osteoporosis.

Authors:  Stefano Coaccioli; Giorgio Celi; Mariano Edoardo Crapa; Francesco Masia; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-05

7.  Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review.

Authors:  Khalaf Ali Al-Jumah; Naseem Akhtar Qureshi
Journal:  Patient Prefer Adherence       Date:  2012-01-31       Impact factor: 2.711

8.  Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.

Authors:  Yi-Wei Yeh; Pei-Shen Ho; Shin-Chang Kuo; Chun-Yen Chen; Chih-Sung Liang; Che-Hung Yen; Chang-Chih Huang; Kuo-Hsing Ma; Chyng-Yann Shiue; Wen-Sheng Huang; Jia-Fwu Shyu; Fang-Jung Wan; Ru-Band Lu; San-Yuan Huang
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-07       Impact factor: 5.176

9.  Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies.

Authors:  Amado Rivero-Santana; Lilisbeth Perestelo-Perez; Jeanette Pérez-Ramos; Pedro Serrano-Aguilar; Carlos De Las Cuevas
Journal:  Patient Prefer Adherence       Date:  2013-03-03       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.